Cargando…

Diagnosis Rates of Chronic Hepatitis B in Privately Insured Patients in the United States

IMPORTANCE: To achieve the World Health Organization goal of viral hepatitis elimination by 2030, it is important to estimate current rates of chronic hepatitis B (CHB) diagnosis and treatment. OBJECTIVE: To provide an accurate accounting of the number of patients with CHB aged 6 years or older who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogawa, Eiichi, Yeo, Yee Hui, Dang, Nolan, Le, Michael H., Jeong, Donghak, Tran, Sally, Henry, Linda, Cheung, Ramsey, Nguyen, Mindie H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146097/ https://www.ncbi.nlm.nih.gov/pubmed/32271388 http://dx.doi.org/10.1001/jamanetworkopen.2020.1844

Ejemplares similares

Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United States
por: Nguyen, Vy H., et al.
Publicado: (2022)

Prevalence of Hepatitis B Vaccination Coverage and Serologic Evidence of Immunity Among US-Born Children and Adolescents From 1999 to 2016
por: Le, Michael H., et al.
Publicado: (2020)

Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia
por: Wei, Bin, et al.
Publicado: (2018)

Real-world effectiveness of sofosbuvir plus ribavirin for chronic hepatitis C genotype 2 in Asia: a systematic review and meta-analysis
por: Wei, Bin, et al.
Publicado: (2018)

County-Level Variation in Cirrhosis-Related Mortality in the US, 1999-2019
por: Ha, Audrey Y., et al.
Publicado: (2022)

Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
por: Le, Michael H., et al.
Publicado: (2022)

Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy
por: Ogawa, Eiichi, et al.
Publicado: (2017)

Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis
por: Park, Haesuk, et al.
Publicado: (2018)

Correction: Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis
por: Park, Haesuk, et al.
Publicado: (2018)

Transient Elastography and Serum-Based Tests for Diagnosis of Fatty Liver and Advanced Fibrosis in a Community Cohort: A Cross-Sectional Analysis
por: Le, Michael H., et al.
Publicado: (2022)

Coverage of Nonpharmacologic Treatments for Low Back Pain Among US Public and Private Insurers
por: Heyward, James, et al.
Publicado: (2018)

Indication-Specific Opioid Prescribing for US Patients With Medicaid or Private Insurance, 2017
por: Mikosz, Christina A., et al.
Publicado: (2020)

Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States
por: Nguyen, Mindie H., et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease and Renal Function Impairment: A Cross‐Sectional Population‐Based Study on Its Relationship From 1999 to 2016
por: Le, Michael H., et al.
Publicado: (2019)

Comparison of Utilization, Costs, and Quality of Medicaid vs Subsidized Private Health Insurance for Low-Income Adults
por: Allen, Heidi, et al.
Publicado: (2021)

Assessment of Perceptions of Mental Health vs Medical Health Plan Networks Among US Adults With Private Insurance
por: Busch, Susan H., et al.
Publicado: (2021)

Higher mortality and hospital charges in patients with cirrhosis and acute respiratory illness: a population-based study
por: Zou, Biyao, et al.
Publicado: (2018)

Associations of Socioeconomic Status, Public vs Private Insurance, and Race/Ethnicity With Metastatic Sarcoma at Diagnosis
por: Diessner, Brandon J., et al.
Publicado: (2020)

Differences in Cancer Care Expenditures and Utilization for Surgery by Hospital Type Among Patients With Private Insurance
por: Takvorian, Samuel U., et al.
Publicado: (2021)

Measuring the Scope of Prior Authorization Policies: Applying Private Insurer Rules to Medicare Part B
por: Schwartz, Aaron L., et al.
Publicado: (2021)

Access to Care, Cost of Care, and Satisfaction With Care Among Adults With Private and Public Health Insurance in the US
por: Wray, Charlie M., et al.
Publicado: (2021)

Geographical Variation in Health Spending Across the US Among Privately Insured Individuals and Enrollees in Medicaid and Medicare
por: Cooper, Zack, et al.
Publicado: (2022)

Rate of hepatocellular carcinoma surveillance remains low for a large, real-life cohort of patients with hepatitis C cirrhosis
por: Tran, Sally Ann, et al.
Publicado: (2018)

Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance
por: Gutin, Liat, et al.
Publicado: (2019)

Assessment of Potentially Preventable Hospital Readmissions After Major Surgery and Association With Public vs Private Health Insurance and Comorbidities
por: Brown, Craig S., et al.
Publicado: (2021)

Medical Service Use and Charges for Cancer Care in 2018 for Privately Insured Patients Younger Than 65 Years in the US
por: Zaorsky, Nicholas G., et al.
Publicado: (2021)

SAT657 Work Loss Among Privately Insured Employees With Overweight And Obesity In The United States
por: Shinde, Shraddha, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States
por: Gao, Xu, et al.
Publicado: (2022)

Treatment Disparities in Radiation and Hormone Therapy Among Women Covered by Medicaid vs Private Insurance in Cancer Registry and Claims Data
por: Bradley, Cathy J., et al.
Publicado: (2023)

Liver Complications in Untreated Treatment-Ineligible versus Treated Treatment-Eligible Patients with Hepatitis B
por: Huang, Daniel Q., et al.
Publicado: (2023)

Changes in dental care use patterns due to COVID-19 among insured patients in the United States
por: Choi, Sung Eun, et al.
Publicado: (2021)

Utilization of basic health units of FHS according to private health insurance
por: Fontenelle, Leonardo Ferreira, et al.
Publicado: (2018)

163 Private or Public Health Insurance and Infant Outcomes in the United States
por: Johnson, Desalyn Louise, et al.
Publicado: (2022)

Antibiotics Dispensed to Privately Insured Pregnant Women with Urinary Tract Infections — United States, 2014
por: Ailes, Elizabeth C., et al.
Publicado: (2018)

Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States
por: Le, Michael H., et al.
Publicado: (2017)

Mo1336: PREVALENCE AND MORTALITY OF ALCOHOL-RELATED LIVER DISEASES DURING COVID-19 PANDEMIC
por: Yeo, Yee Hui, et al.
Publicado: (2022)

Advancing Age and Comorbidity in a US Insured Population‐Based Cohort of Patients With Chronic Hepatitis B
por: Nguyen, Mindie H., et al.
Publicado: (2019)

New Proposal of Private Insurance Program for Dementia Patients: Design of Sustainable Private Insurance Program in Korea
por: Park, Kun-Woo, et al.
Publicado: (2017)

Comparison of renal safety of tenofovir and entecavir in patients with chronic hepatitis B: Systematic review with meta-analysis
por: Lee, Hyo-Young, et al.
Publicado: (2019)

Transitions in Health Insurance During the Perinatal Period Among Patients With Continuous Insurance Coverage
por: Jeung, Chanup, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jif3frmtvpujcufi3vdr348iai